Are drug regulators sufficiently independent from the companies they are meant to regulate?
A viral reprise: When COVID-19 strikes again and again
29 June 2022Privatizing NHS services associated with decline in quality of healthcare, increasing deaths from treatable causes
30 June 2022Are drug regulators sufficiently independent from the companies they are meant to regulate?
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of new medicines before they hit the market. But an investigation published by The BMJ today finds that industry money permeates the globe’s leading regulators, raising questions about their independence, especially in the wake of a string of drug and device scandals.
